Anthem (NASDAQ:ANTX) Insider Joshua Eizen Sells 5,945 Shares

Anthem, Inc. (NASDAQ:ANTXGet Free Report) insider Joshua Eizen sold 5,945 shares of the company’s stock in a transaction that occurred on Wednesday, July 8th. The stock was sold at an average price of $4.17, for a total value of $24,790.65. Following the completion of the sale, the insider owned 206,554 shares in the company, valued at $861,330.18. The trade was a 2.80% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Anthem Price Performance

ANTX stock traded down $0.13 on Friday, reaching $4.50. 591,722 shares of the company traded hands, compared to its average volume of 422,831. The firm has a fifty day simple moving average of $4.60 and a 200-day simple moving average of $3.11. The company has a market cap of $162.09 million, a P/E ratio of -4.09 and a beta of -0.99. Anthem, Inc. has a one year low of $1.00 and a one year high of $6.91.

Anthem (NASDAQ:ANTXGet Free Report) last released its earnings results on Monday, May 11th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.23) by ($0.06).

Institutional Trading of Anthem

Several institutional investors have recently added to or reduced their stakes in ANTX. Bank of America Corp DE raised its stake in shares of Anthem by 2.2% in the first quarter. Bank of America Corp DE now owns 393,702 shares of the company’s stock worth $1,346,000 after purchasing an additional 8,390 shares during the last quarter. OMERS ADMINISTRATION Corp purchased a new stake in shares of Anthem during the first quarter valued at $54,000. Seven Fleet Capital Management LP purchased a new stake in shares of Anthem during the first quarter valued at $683,000. Vivo Capital LLC bought a new stake in Anthem in the 1st quarter worth about $10,785,000. Finally, ADAR1 Capital Management LLC bought a new stake in Anthem in the 1st quarter worth about $47,000. 90.47% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

ANTX has been the topic of a number of analyst reports. Wall Street Zen upgraded shares of Anthem from a “sell” rating to a “hold” rating in a research note on Sunday, June 14th. Weiss Ratings restated a “sell (d-)” rating on shares of Anthem in a research note on Monday. Finally, Leerink Partners raised shares of Anthem from a “market perform” rating to an “outperform” rating and set a $9.00 target price for the company in a report on Thursday, May 14th. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Anthem has an average rating of “Hold” and an average target price of $9.00.

Read Our Latest Stock Report on Anthem

About Anthem

(Get Free Report)

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.

See Also

Insider Buying and Selling by Quarter for Anthem (NASDAQ:ANTX)

Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.